Epigral Ltd Analyst Rating
based on 1 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 1 analysts offering long term price targets for Epigral Ltd. An average target of ₹2000
Source: S&P Global Market Intelligence
Epigral Ltd Share analysis
Epigral Ltd price forecast by 1 analysts
Downside of
High
₹2000
Target
₹2000.00
Low
₹2000
Epigral Ltd target price ₹2000, a slight downside of -0.26% compared to current price of ₹1966.05. According to 1 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Epigral Ltd revenue growth forecast
Expected growth rate Q1, FY2026:45.54%
Forecast
Actual
Including amortisation and stock based compensations
Epigral Ltd EPS growth forecast
EPS estimate Q1, FY2026:13.37%
Forecast
Actual
Source: S&P Global Market Intelligence
Epigral Ltd Performance
Day's Low
Day's High
₹1,949Day's Price Range₹2,04052 Week's Low
52 Week's High
₹888.152-Week Price Range₹2,406.75
| Returns % | |
| 1 Month Return | + 3.95 % |
| 3 Month Return | -4.2 % |
| 1 Year Return | + 122.48 % |
| Market Stats | |
| Previous Close | ₹2,005.25 |
| Open | ₹2,023.10 |
| Volume | 38.25K |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹8,505.10Cr |
Epigral Ltd Key Statistics
| P/E Ratio | 28.38 |
| PEG Ratio | 1.68 |
| Market Cap | ₹8,505.10 Cr |
| P/B Ratio | 3.63 |
| EPS | 47.14 |
| Dividend Yield | 0.46 |
| Sector | Chemicals |
| ROE | 16.85 |
Epigral Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹8,505.10 Cr | 78.67% | 0.71 | ₹195 Cr | ₹1,929 Cr | |
| NA | ₹262.88 Cr | 16% | 0.58 | NA | NA | |
| NA | ₹402.65 Cr | 28.53% | 0.50 | NA | NA | |
| NA | ₹138.96 Cr | 242.95% | 0.50 | NA | NA | |
| NA | ₹24.26 Cr | 56.46% | 0.76 | NA | NA |
About Epigral Ltd
Share Price: ₹1966.05 per share as on 20 Dec, 2024 04:01 PM
Market Capitalisation: ₹8,505.10Cr as of today
Revenue: ₹626.06Cr as on September 2024 (Q3 24)
Net Profit: ₹81.30Cr as on September 2024 (Q3 24)
Listing date: 18 Aug, 2021
Chairperson Name: Maulik Jayantibhai Patel
| Organisation | Epigral Ltd |
| Headquarters | Ahmedabad |
| Industry | Chemicals |
| E-voting on shares | Click here to vote |
Key events for Epigral Ltd
Epigral Targets Double-Digit Growth with Expansion Plans - 24 Nov, 2024
Epigral aims for double-digit volume growth over five years, focusing on expanding manufacturing capacity for chlorine derivatives. Recent QIP raised Rs 333 crore for funding, with expectations of improved performance in Q3 and Q4.Epigral Reports Strong Q2 Results Amid Capacity Expansion - 09 Nov, 2024
Epigral Ltd's Board approved a significant capacity expansion at its Dahej plant. The company reported a more than two-fold increase in Q2FY25 profit to Rs 81 crore, with revenue rising 32%. However, shares fell by 3.11% on the same day.
Insights on Epigral Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTFII Holding Up
Foreign Institutions have increased holdings from 2.09% to 3.02% in Oct 2024 quarter
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 1.04% to 3.68% in Oct 2024 quarter
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, EPIGRAL has outperformed top 5 stocks with highest market-cap in Commodity Chemicals
NO EFFECTAgainst Peers
In the last 3 years, Solar Industries India Ltd has given 334.5% return, outperforming this stock by 160.6%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, 85.87 Cr → 81.3 Cr (in ₹), with an average decrease of 5.3% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 7 days, EPIGRAL stock has moved down by -7.2%
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 653.6 Cr → 632.38 Cr (in ₹), with an average decrease of 3.3% per quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 25.13% to 24.20% in Oct 2024 quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 71.58% to 68.94% in Oct 2024 quarter
Epigral Ltd Financials
Index Inclusions
Epigral Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 68.94% | ||
| Foreign Institutions | 3.02% | 44.38 | |
| Mutual Funds | 3.68% | 254.99 | |
| Retail Investors | 24.2% | ||
| Others | 0.15% |
Epigral Ltd Key Indicators
Epigral Ltd Valuation
Epigral Ltd in the last 5 years
Lowest (9.04x)
March 28, 2023
Today (28.38x)
December 19, 2024
Industry (59.45x)
December 19, 2024
Highest (38.05x)
September 24, 2024
Epigral Ltd Earnings and Dividends
Epigral Ltd Dividends April,2024
In the quarter ending March 2024, Epigral Ltd has declared dividend of ₹5 - translating a dividend yield of 0.38%.
Read More about Dividends
Epigral Ltd Technicals Summary
Bearish
Neutral
Bullish
Epigral Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Epigral Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Epigral Ltd shares.
Epigral Ltd (EPIGRAL) share price today is ₹1966.05
Epigral Ltd is listed on NSE
Epigral Ltd is listed on BSE
- Today’s highest price of Epigral Ltd is ₹2040.
- Today’s lowest price of Epigral Ltd is ₹1949.
PE Ratio of Epigral Ltd is 28.38
PE ratio = Epigral Ltd Market price per share / Epigral Ltd Earnings per share
Today’s traded volume of Epigral Ltd(EPIGRAL) is 38.25K.
Today’s market capitalisation of Epigral Ltd(EPIGRAL) is ₹8505.1Cr.
| Epigral Ltd(EPIGRAL | Price |
|---|---|
52 Week High | ₹2406.75 |
52 Week Low | ₹888.1 |
Epigral Ltd(EPIGRAL) share price is ₹1966.05. It is down -18.31% from its 52 Week High price of ₹2406.75
Epigral Ltd(EPIGRAL) share price is ₹1966.05. It is up 121.38% from its 52 Week Low price of ₹888.1
| Epigral Ltd(EPIGRAL | Returns |
|---|---|
1 Day Returns | -39.2% |
1 Month Returns | 3.95% |
3 Month Returns | -4.2% |
1 Year Returns | 122.48% |